A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas

• Status: Completed
• Trial end date: 2008-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this trial is to understand if adding saxagliptin to a sulfonylurea is safe and works better than increasing the amount of sulfonylurea a patient takes

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Glyburide; Metformin; Saxagliptin

Criteria

Inclusion Criteria:

• Type 2 Diabetes.

• Treated with a sulfonylurea for at least 2 months.

• Inadequate blood sugar control.

• Are not on any other medications to lower blood sugar.

• No major heart, liver or kidney problems.

• Women not pregnant or breast feeding.